Translational Oncogenomics
Synopsis: An open access, peer reviewed electronic journal that covers novel genetic, epigenetic and molecular pathway information related to clinical cancer.
Indexing: 6 major databases. Pubmed indexing for NIH-funded research.
Processing time: Decision in 2 weeks for 90% of papers.
Latest news:
View factor:
Journal: 73560
Most read article: 3498
Editor in chief:
Michael Spinella
ISSN: 1177-2727
Translational Oncogenomics call for papers from Dr Michael Spinella
General call for papers (scroll down for 2010 special issue)
On behalf of the Editorial board I invite you to submit your next article to Translational Oncogenomics, an open access electronic journal published by Libertas Academica. The journal specializes in providing wide and open access for high quality genomic scale data related to human cancer etiology, detection, prognosis and treatment. We accept original studies in basic and applied oncogenomics and thoughtful reviews, surveys, opinions, commentaries, techniques, and essays. All submitted articles will be considered and peer-reviewed.
We look forward to receiving your manuscript.
What is the advantage to you of publishing in Translational Oncogenomics?
- Full open access: everyone can read your article and you retain copyright in it
- Publishing decision within 2 weeks of submission
- Your paper will not be rejected due to lack of space and will be published immediately on acceptance
- Prompt and fair peer review from two expert peer reviewers
- Frequent updates on your paper’s status
- Friendly responsive staff
What a previous author said:
"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."
In summary:
The advantages of a younger journal such as Translational Oncogenomics are numerous but in essence allow us a greater flexibility and responsiveness to authors and readers that older journals cannot match.
Yours sincerely,
Dr Michael Spinella
Editor-in-Chief
Translational Oncogenomics
2010 special issue call for papers
Dear colleagues,
I invite you to submit a paper to the forthcoming special issue of Translational Oncogenomics.
About the special issue
This special issue is titled "Transcriptomes and Epigenomes in Cancer".
The aim of this special issue is to provide a forum for timely primary articles and reviews on genome wide transcriptional and epigenetic regulation during cancer progression and response to therapy.
Papers within the scope of this special issue include:
Registration of manuscripts: 1 May 2010
Manuscripts submitted: 1 June 2010
Completion of peer review: circa 1 July 2010
Resubmission of revised manuscripts: circa 1 September 2010
How to participate
To register your manuscript visit this page. All manuscripts are subject to approval by the Editor in Chief.
Article processing fees
Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.
Editorial board members are encouraged to make use of the special benefits available to them.
General call for papers
A general call for papers was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.
Your sincerely,
Michael Spinella,
Editor in Chief
Translational Oncogenomics
I invite you to submit a paper to the forthcoming special issue of Translational Oncogenomics.
About the special issue
This special issue is titled "Transcriptomes and Epigenomes in Cancer".
The aim of this special issue is to provide a forum for timely primary articles and reviews on genome wide transcriptional and epigenetic regulation during cancer progression and response to therapy.
Papers within the scope of this special issue include:
- Gene expression profiling, including microarray and deep-sequencing studies related to cancer initiation, progression, diagnosis and response to therapy.
- Genome wide transcription factor binding of oncogenes and tumor suppressor genes.
- Epigenetic regulation of the chromatin landscape in cancer.
- Large-scale DNA methylation analysis.
- miRNA profiling.
- Review articles in the area of transcriptomics and epigenomics focused on tumor type and/or response to a class of therapeutics. Examples: the transcriptome of cancer stem cells, gene profiles associated with metastasis, tumor response to cytotoxic or targeted therapies.
- Original papers or review articles on bioinformatic, statistical and computational methods that support genome-wide studies.
- Commentaries and perspectives related to Transcriptomes and Epigenomes in Cancer.
Registration of manuscripts: 1 May 2010
Manuscripts submitted: 1 June 2010
Completion of peer review: circa 1 July 2010
Resubmission of revised manuscripts: circa 1 September 2010
How to participate
To register your manuscript visit this page. All manuscripts are subject to approval by the Editor in Chief.
Article processing fees
Submissions are welcomed from individuals not on the editorial board. An article processing fee will be charged in recognition of the journal’s open access status.
Editorial board members are encouraged to make use of the special benefits available to them.
General call for papers
A general call for papers was recently announced. I continue to welcome submissions to the general volume. Manuscripts may be submitted at any time.
Your sincerely,
Michael Spinella,
Editor in Chief
Translational Oncogenomics
Translational Oncogenomics
Michael Spinella, Editor in Chief
Submit a paper
Share this journal
 |
|
 |
YAHOO! BUZZ |
 |
DIGG |
 |
|
 |
MIXX |
 |
PERMALINK |
 |
GOOGLE BOOKMARKS |
 |
DELICIOUS |
 |
|
 |
NEWSVINE |
Recent news
Seven more journals added to CAS
- 26/Jan/2010
Author interview with Dr Hiro Koshiyama - 28/Jan/2010
Author interview with Dr Nicolas Carels - 22/Jan/2010
Interview with Clinical Medicine Insights: Cardiology editorial board meber Dr Arnon Blum - 12/Jan/2010
Five more journals accepted by DOAJ - 05/Jan/2010
Open access articles published in December - 04/Jan/2010
Open access articles published in November - 09/Dec/2009
2010 special issues - 07/Dec/2009
Proposals invited for Translational Oncogenomics special issue - 07/Dec/2009
Proposals invited for Signal Transduction Insights special issue - 07/Dec/2009
Proposals invited for Rehabilitation Process and Outcome special issue - 07/Dec/2009
Proposals invited for Primary Prevention Insights special issue - 07/Dec/2009
Proposals invited for Perspectives in Medicinal Chemistry special issue - 07/Dec/2009
Proposals invited for Palliative Care: Research and Treatment special issue - 07/Dec/2009
Proposals invited for Immunotherapy Insights special issue - 07/Dec/2009
Proposals invited for Human Parasitic Diseases special issue - 07/Dec/2009
Proposals invited for Healthy Aging and Clinical Care in the Elderly special issue - 07/Dec/2009
Proposals invited for Genomics Insights special issue - 07/Dec/2009
Proposals invited for Genetics and Epigenetics special issue - 07/Dec/2009
Proposals invited for Environmental Health Insights special issue - 04/Dec/2009
Author interview with Dr Hiro Koshiyama - 28/Jan/2010
Author interview with Dr Nicolas Carels - 22/Jan/2010
Interview with Clinical Medicine Insights: Cardiology editorial board meber Dr Arnon Blum - 12/Jan/2010
Five more journals accepted by DOAJ - 05/Jan/2010
Open access articles published in December - 04/Jan/2010
Open access articles published in November - 09/Dec/2009
2010 special issues - 07/Dec/2009
Proposals invited for Translational Oncogenomics special issue - 07/Dec/2009
Proposals invited for Signal Transduction Insights special issue - 07/Dec/2009
Proposals invited for Rehabilitation Process and Outcome special issue - 07/Dec/2009
Proposals invited for Primary Prevention Insights special issue - 07/Dec/2009
Proposals invited for Perspectives in Medicinal Chemistry special issue - 07/Dec/2009
Proposals invited for Palliative Care: Research and Treatment special issue - 07/Dec/2009
Proposals invited for Immunotherapy Insights special issue - 07/Dec/2009
Proposals invited for Human Parasitic Diseases special issue - 07/Dec/2009
Proposals invited for Healthy Aging and Clinical Care in the Elderly special issue - 07/Dec/2009
Proposals invited for Genomics Insights special issue - 07/Dec/2009
Proposals invited for Genetics and Epigenetics special issue - 07/Dec/2009
Proposals invited for Environmental Health Insights special issue - 04/Dec/2009
Similar papers
Bimodal Gene Expression and Biomarker Discovery - 04/Feb/2010
A Robust Gene Selection Method for Microarray-based Cancer Classification - 04/Feb/2010
Dual KS: Defining Gene Sets with Tissue Set Enrichment Analysis - 21/Jan/2010
Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas - 20/Jan/2010
A Case of Protruding Eyeballs and Diminishing Vision - 20/Jan/2010
BITC Sensitizes Pancreatic Adenocarcinomas to TRAIL-induced Apoptosis - 20/Jan/2010
Adjuvant Gemcitabine-Oxaliplatin (GEMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma - 18/Jan/2010
A Novel Approach for Analysis of the Log-Linear Age-Period-Cohort Model: Application to Lung Cancer Incidence - 14/Dec/2009
Orbital Metastasis of Breast Carcinoma - 02/Dec/2009
A Cancer Gene Therapy Approach that Targets Tumor-associated Hyaluronan - 30/Nov/2009
Common Variable Immunodeficiency Associated with Inflammatory Bowel Disease and Type I Diabetes - 27/Nov/2009
In silico Analysis of Human Telomerase Reverse Transcriptase (hTERT ) Gene: Identification of a Distant Homolog of Melanoma Antigen Family Gene (MAGE) - 24/Nov/2009
Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR Patterns of Care Study - 24/Nov/2009
Discrimination of Carcinogens by Hepatic Transcript Profiling in Rats Following 28-day Administration - 13/Nov/2009
Characterization of a Test for Invasive Breast Cancer Using X-ray Diffraction of Hair - Results of a Clinical Trial - 10/Nov/2009
A Robust Gene Selection Method for Microarray-based Cancer Classification - 04/Feb/2010
Dual KS: Defining Gene Sets with Tissue Set Enrichment Analysis - 21/Jan/2010
Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas - 20/Jan/2010
A Case of Protruding Eyeballs and Diminishing Vision - 20/Jan/2010
BITC Sensitizes Pancreatic Adenocarcinomas to TRAIL-induced Apoptosis - 20/Jan/2010
Adjuvant Gemcitabine-Oxaliplatin (GEMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma - 18/Jan/2010
A Novel Approach for Analysis of the Log-Linear Age-Period-Cohort Model: Application to Lung Cancer Incidence - 14/Dec/2009
Orbital Metastasis of Breast Carcinoma - 02/Dec/2009
A Cancer Gene Therapy Approach that Targets Tumor-associated Hyaluronan - 30/Nov/2009
Common Variable Immunodeficiency Associated with Inflammatory Bowel Disease and Type I Diabetes - 27/Nov/2009
In silico Analysis of Human Telomerase Reverse Transcriptase (hTERT ) Gene: Identification of a Distant Homolog of Melanoma Antigen Family Gene (MAGE) - 24/Nov/2009
Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR Patterns of Care Study - 24/Nov/2009
Discrimination of Carcinogens by Hepatic Transcript Profiling in Rats Following 28-day Administration - 13/Nov/2009
Characterization of a Test for Invasive Breast Cancer Using X-ray Diffraction of Hair - Results of a Clinical Trial - 10/Nov/2009